Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
Benjamin D. Moncarz Chief Financial Officer - FDA | Official Website
This is a 200% increase over the number of companies inspected in the previous quarter, when one company received one inspection.
Most of the companies inspected at the time were involved in the Devices sector. The second most common type of company inspected worked in the Biologics sector.
There were two companies in line with FDA regulations that do not need to adjust their management operations or regulatory/administrative actions. One should take voluntary action to correct its management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Community Blood Center | Biologics | 03/24/2023 | No Action Indicated (NAI) |
Community Blood Center | Devices | 03/24/2023 | No Action Indicated (NAI) |
M3 Global Enterprises, LLC | Devices | 02/16/2023 | Voluntary Action Indicated (VAI) |
Vestibular Research and Development, LLC | Devices | 03/06/2023 | No Action Indicated (NAI) |